RecruitingNCT06211517

Drugs Experience for Adolescents With Anorexia

Subjective Experience of Psychotropic Drugs Among Adolescents (Their Parents and Professionals) With Anorexia Nervosa


Sponsor

Assistance Publique - Hôpitaux de Paris

Enrollment

90 participants

Start Date

May 20, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to access to the experiences of adolescents, their parents and healthcare professionals regarding psychotropic drugs in anorexia nervosa. No preconceived ideas (according to qualitative methods) but a question: what are the participants' perceptions and experiences of psychotropic drugs in anorexia nervosa? In an adolescent medicine department.


Eligibility

Min Age: 12 Years

Inclusion Criteria5

  • Adolescents :
  • Aged 12 to 25 years
  • Suffering from anorexia nervosa (restrictive or mixed) according to DSM-5 (Diagnostic and Statistical Manual) criteria
  • Received psychotropic drugs (antidepressant treatment and/or APA) during their care, either ongoing or discontinued before this study started
  • Healthcare Professionals working with adolescents suffering from eating disorders

Exclusion Criteria5

  • Adolescents :
  • Atypical eating disorder that does not meet the DSM-5 criteria for restrictive or mixed anorexia nervosa
  • BMI<15
  • Prescription of an antidepressant other than an SSRI (Selective Serotonin Reuptake Inhibitor)
  • Prescription of an APA for the indication of psychotic symptoms

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERSemi-structured interviews with visual mediations

Semi-structured interviews with visual mediations / An hour-long interview

OTHERSemi-structured interviews

Semi-structured interviews


Locations(1)

Maison de Solenn Maison des Adolescents, Cochin Hospital

Paris, IDF, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06211517


Related Trials